TRK 851

Drug Profile

TRK 851

Latest Information Update: 29 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Toray
  • Developer Mitsubishi Pharma Corporation; Toray
  • Class Antitussives
  • Mechanism of Action Opioid delta receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cough

Most Recent Events

  • 03 Apr 2001 A preclinical study has been added to the adverse events and Respiratory Disorders pharmacodynamics sections
  • 31 Jan 2001 Phase-I clinical trials for Cough in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top